Showing results (141-150 of 254) with videos related to
Sort By:
Pageof 26
International Journal of Antimicrobial Agents|July 4, 2026
Real world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir + rilpivirineGreta Marchegiani, Francesco Paolo Antonucci, Ada Bertoli, et al.AIDS Research and Human Retroviruses|February 3, 2009
Dynamics of NRTI resistance mutations during therapy interruptionMaria Trignetti, Tobias Sing, Valentina Svicher, et al.Life (Basel, Switzerland)|November 26, 2020
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute CholecystitisRossana Scutari, Lorenzo Piermatteo, Matteo Ciancio Manuelli, et al.The Journal of Antimicrobial Chemotherapy|May 21, 2013
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimenClaudia Alteri, Anna Artese, Gertjan Beheydt, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 30, 2016
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNAMauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, et al.Virus Genes|February 24, 2019
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practiceClaudia Alteri, Rossana Scutari, Ada Bertoli, et al.Antimicrobial Agents and Chemotherapy|May 19, 2010
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitorsFrancesca Ceccherini-Silberstein, Kurt Van Baelen, Daniele Armenia, et al.Antiviral Research|February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitroValentina Svicher, Emanuela Balestra, Valeria Cento, et al.The Journal of Antimicrobial Chemotherapy|September 6, 2011
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencingClaudia Alteri, Maria Mercedes Santoro, Isabella Abbate, et al.Chemmedchem|September 29, 2011
Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirineStefano Alcaro, Claudia Alteri, Anna Artese, et al.Pageof 26